Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4378 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Leiner Health launches nutritional supplements

The Wheaties Multivitamins provide 100% of 17 essential vitamins and minerals; in addition Wheaties Daily Performance Vitamin Packs offer consumers an energy enhancing supplement. The company said its

Salix and Altana join to promote antibiotic

Under the terms of the agreement, Altana Pharma US will use one of its sales forces with approximately 250 representatives to promote Xifaxan (rifaximin) tablets 200mg to the

Flamel ends licensing deal with Biovail

The license agreement for Genvir (acyclovir), which was signed in February 2003, granted a license to Biovail in the US and Canada, subject to Biovail’s initiation of certain

Cytokinetics selects heart failure candidate

The selected compound is currently in preclinical studies and, based on the successful completion of the preclinical program, Cytokinetics intends to submit a regulatory filing for the initiation

Impax launches OxyContin generic

The FDA granted final approval to the company’s abbreviated new drug application for the generic OxyContin (oxycodone hydrochloride) controlled release 80mg tablets in late September 2004. Impax agreed

Labopharm adds Russia to pain drug agreement

In 2004, Labopharm signed an agreement with CSC under which it granted CSC the exclusive right to market and sell Labopharm’s once-daily formulation of the pain drug tramadol

Genzyme’s Thyrogen gets EU OK

The new label for Thyrogen (thyrotropin alfa for injection) permits the product’s use in the EU for the ablation of remnant thyroid tissue, a procedure that patients commonly